Prostate Cancer

Our nationally and internationally known specialists offer comprehensive services that include the most up-to-date, research-backed approaches to prostate cancer screening, diagnosis, treatment, post-treatment rehabilitation, and integrative therapies.

Our doctors share in the growing consensus among top prostate cancer specialists that many men are being overtreated for prostate cancer. We work together to identify which men are best served by aggressive treatment and which can be treated safely with a more conservative approach. We believe in empowering you with information, so that you can be an active partner in creating a personalized treatment plan that’s right for you.

Clinical Trials and Research Studies

Phase 1

An Open-label Multicenter Phase 1b Study of JNJ-63723283 a PD-1 Inhibitor Administered in Combination with Apalutamide in Subjects with Metastatic Castration-Resistant Prostate Cancer

Learn More

Phase N/A

Prospective Multi-Center Study of the ClariCore TM Optical Biopsy System in Patients Undergoing Transperineal Prostate Biopsy for Prostate Tissue Classification Algorithm Development

Learn More

Phase 1/2

ProSTAR: A Phase 1b/2 Study of CPI-1205 a Small Molecule Inhibitor of EZH2 Combined with Enzalutamide or Abiraterone/Prednisone in Patients with Metastatic Castration Resistant Prostate Cancer

Learn More

Phase 1/2

A PHASE 1B/2 STUDY TO EVALUATE SAFETY AND ANTI-TUMOR ACTIVITY OF AVELUMAB IN COMBINATION WITH THE POLY (ADENOSINE DIPHOSPHATE [ADP]-RIBOSE) POLYMERASE (PARP) INHIBITOR TALAZOPARIB IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC SOLID TUMORS

Learn More